WINDTREE THERAPEUTICS INC /DE/ (WINT): debt financing — Windtree issues $857K convertible note due 2026 to fund CommLoan acquisition advance

WINDTREE THERAPEUTICS INC /DE/

Issued $857,142.86 in senior convertible notes to an institutional investor; interest 10% per annum, maturity Nov 26, 2026.
Proceeds: $450,000 advanced to CommLoan Inc. towards a planned acquisition; $150,000 retained for general corporate purposes.
Conversion price set at 90% of the lowest sale price over 20 consecutive trading days; beneficial ownership cap 4.99% (increaseable to 9.99%).
Note includes mandatory prepayment triggers: 25% of proceeds from existing stock purchase agreement at 115% premium; full repayment upon $1M+ equity financing.
Company must file resale registration statement within 45 days for shares underlying the note.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ incurred convertible notes of $857,142.86 with an institutional investor at 10% per annum maturing November 26, 2026.

Instrument: convertible notes
Principal: $857,142.86
Counterparty: an institutional investor
Rate: 10% per annum
Maturity: November 26, 2026
Event: incurrence

Exact text from the filing

issued to an institutional investor (the “Holder”) an aggregate principal amount of $857,142.86 in senior convertible promissory notes due 2026 (the “2026 Notes”).

View on SEC.gov

311 debt financings filed in the last 30 days. Browse all debt financings →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR

accession 0001437749-25-036665

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.